BACKGROUND: The Breast Cancer Initiative (BCI) was started in 2002 to disseminate breast cancer decision aids (PtDAs) to providers. METHODS: We analysed BCI programme data for 195 sites and determined the proportion of sites involved in each of five stages of dissemination and implementation of PtDAs. We conducted cross-sectional mail and telephone surveys of 79 sites with the most interest in implementation. We examined barriers associated with sustained use of the PtDAs. RESULTS: Since 2002 we attempted contact with 195 sites to join the BCI. The majority indicated interest in using PtDAs 172 of 195 (88%), 93 of 195 signed up for the BCI (48%), 57 of 195 reported distributing PtDAs to at least one patient (57%), and 46 of 195 reported sustained use (24%). We analysed data from interviews with 59 of 79 active sites (75% response rate). The majority of providers 49 of 59 (83%) had watched the PtDAs, and 46 of 59 (78%) distributed them to patients. The most common barriers were lack of a reliable way to identify patients before decisions are made (37%), a lack of time to distribute the PtDAs (22%) and having too many educational materials (15%). Sites that indicated a lack of clinician support as a barrier were significantly less likely to have sustained use compared to sites that didn't (33% vs. 74%, P = 0.02). CONCLUSIONS: Community breast cancer providers, both physicians and non-physicians, express a high interest in using PtDAs with their patients. About a quarter of sites report sustained use of the PtDAs in routine care.
BACKGROUND: The Breast Cancer Initiative (BCI) was started in 2002 to disseminate breast cancer decision aids (PtDAs) to providers. METHODS: We analysed BCI programme data for 195 sites and determined the proportion of sites involved in each of five stages of dissemination and implementation of PtDAs. We conducted cross-sectional mail and telephone surveys of 79 sites with the most interest in implementation. We examined barriers associated with sustained use of the PtDAs. RESULTS: Since 2002 we attempted contact with 195 sites to join the BCI. The majority indicated interest in using PtDAs 172 of 195 (88%), 93 of 195 signed up for the BCI (48%), 57 of 195 reported distributing PtDAs to at least one patient (57%), and 46 of 195 reported sustained use (24%). We analysed data from interviews with 59 of 79 active sites (75% response rate). The majority of providers 49 of 59 (83%) had watched the PtDAs, and 46 of 59 (78%) distributed them to patients. The most common barriers were lack of a reliable way to identify patients before decisions are made (37%), a lack of time to distribute the PtDAs (22%) and having too many educational materials (15%). Sites that indicated a lack of clinician support as a barrier were significantly less likely to have sustained use compared to sites that didn't (33% vs. 74%, P = 0.02). CONCLUSIONS: Community breast cancer providers, both physicians and non-physicians, express a high interest in using PtDAs with their patients. About a quarter of sites report sustained use of the PtDAs in routine care.
Authors: Margaret Holmes-Rovner; Diane Valade; Catherine Orlowski; Catherine Draus; Barbara Nabozny-Valerio; Susan Keiser Journal: Health Expect Date: 2000-09 Impact factor: 3.377
Authors: Annette M O'Connor; Carol Bennett; Dawn Stacey; Michael J Barry; Nananda F Col; Karen B Eden; Vikki Entwistle; Valerie Fiset; Margaret Holmes-Rovner; Sara Khangura; Hilary Llewellyn-Thomas; David R Rovner Journal: Med Decis Making Date: 2007-09-14 Impact factor: 2.583
Authors: E Dale Collins; Caroline P Moore; Kate F Clay; Stephen A Kearing; Annette M O'Connor; Hilary A Llewellyn-Thomas; Richard J Barth; Karen R Sepucha Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Ian D Graham; Jo Logan; Annette O'Connor; Karen E Weeks; Shawn Aaron; Ann Cranney; Robert Dales; Thomas Elmslie; Paul Hebert; Elaine Jolly; Andreas Laupacis; Susan Mitchell; Peter Tugwell Journal: Patient Educ Couns Date: 2003-07
Authors: Mara A Schonberg; Alicia R Jacobson; Gianna M Aliberti; Michelle Hayes; Anne Hackman; Maria Karamourtopolous; Christine Kistler Journal: J Gen Intern Med Date: 2019-09-04 Impact factor: 5.128
Authors: Jennifer L Tucholka; Dou-Yan Yang; Jordan G Bruce; Nicole M Steffens; Jessica R Schumacher; Caprice C Greenberg; Lee G Wilke; Jennifer Steiman; Heather B Neuman Journal: J Am Coll Surg Date: 2017-12-12 Impact factor: 6.113
Authors: Mary Ann O'Brien; Cathy Charles; Peter Lovrics; Frances C Wright; Tim Whelan; Marko Simunovic; Erin Kennedy; Eva Grunfeld Journal: Implement Sci Date: 2014-11-29 Impact factor: 7.327
Authors: William B Brinkman; Ellen A Lipstein; Janalee Taylor; Pamela J Schoettker; Katherine Naylor; Karla Jones; Sheetal S Vora; Catherine C Mims; Elizabeth Roth-Wojcicki; Beth Gottlieb; Nancy Griffin; Carole Lannon; Esi Morgan Journal: Pediatr Rheumatol Online J Date: 2017-06-05 Impact factor: 3.054
Authors: Glyn Elwyn; Isabelle Scholl; Caroline Tietbohl; Mala Mann; Adrian G K Edwards; Catharine Clay; France Légaré; Trudy van der Weijden; Carmen L Lewis; Richard M Wexler; Dominick L Frosch Journal: BMC Med Inform Decis Mak Date: 2013-11-29 Impact factor: 2.796
Authors: Anik M C Giguere; Michel Labrecque; R Brian Haynes; Roland Grad; Pierre Pluye; France Légaré; Michel Cauchon; Matthew Greenway; Pierre-Hugues Carmichael Journal: Implement Sci Date: 2014-10-05 Impact factor: 7.327